Clinical Trial

The MIND-BC Study: MIND Diet for Breast Cancer Cognition

Study acronym: MIND-BC
Recruiting
View on ClinicalTrials.gov →
Summary
This fully, powered efficacy RCT, the MIND diet for Breast Cancer Cognition (MIND-BC), will evaluate the MIND diet in a rigorous, highly controlled academic cancer center. We will recruit breast cancer survivors reporting CRCI with a MIND diet score \< 8, based on a previously devised 14-item diet questionnaire designed to detect inadequate diet with respect to brain health (scores range from 0 to 14, with lower scores indicating a less adequate diet).14 Breast cancer survivors will have recently completed adjuvant treatment (i.e., 6 months to three years previously), to ensure that perceived cognitive impairment is likely chronic and due to cancer. To achieve maximal effect, the study consists of two 12-week phases 1) intervention phase, 2) maintenance phase.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-06-05; most recent amendment 2026-02-03.
Status change: Not Yet Recruiting → Recruiting 2025-10-30
Trial Details
NCT Number NCT07018986
Lead Sponsor H. Lee Moffitt Cancer Center and Research Institute
Collaborators: National Cancer Institute (NCI)
Conditions Breast Cancer
Enrollment 200 participants
Start Date 2025-07-09
Primary Completion 2029-03 (estimated)
Study Completion 2030-03 (estimated)
Updated on ClinicalTrials.gov 2026-02-05